Screener
Bioventus BVS Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Bioventus’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|---|---|
| Comprehensive income attributable to noncontrolling interest | (2,984) | (2,118) | (3,728) | (1,555) |
| Comprehensive income attributable to Bioventus Inc. | $34,392 | $8,747 | $37,126 | $6,621 |
| Income per share of Class A common stock: | ||||
| Basic | $0.49 | $0.11 | $0.54 | $0.07 |
| Diluted | $0.47 | $0.11 | $0.52 | $0.07 |
| Weighted-average shares of Class A common stock outstanding: | ||||
| Basic | 67,869,148 | 66,500,433 | 67,589,178 | 66,258,679 |
| Diluted | 70,838,486 | 68,536,759 | 70,429,825 | 68,765,591 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Bioventus's shares (diluted)?
- Bioventus (BVS) reported shares (diluted) of 70.8M in Q2 2026.
- How has Bioventus's shares (diluted) changed year-over-year?
- Bioventus's shares (diluted) increased by 3.4% year-over-year, from 68.5M to 70.8M.
- What is the long-term trend for Bioventus's shares (diluted)?
- Over 4 years (2021 to 2025), Bioventus's shares (diluted) has grown at a 12.3% compound annual growth rate (CAGR), from 170.9M to 272.3M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Bioventus's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude